Arrowhead Pharmaceuticals, Inc. (ARWR) vs TG Therapeutics, Inc. (TGTX)
Arrowhead Pharmaceuticals, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and TG Therapeutics, Inc. are of similar size ($9.3B and $8.8B). Arrowhead Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; TG Therapeutics, Inc. trades at 18.9×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 16.1%. TG Therapeutics, Inc. has the higher net margin (55.2% vs −47.8%) and the higher return on invested capital (10.7% vs 0.00%). Across the 18 metrics below, TG Therapeutics, Inc. leads on 15 and Arrowhead Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ARWR | TGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.37% | 65.16% |
| Operating margin | (33.82%) | 17.05% | 0.00% |
| Net margin | (47.79%) | 55.22% | 0.00% |
| Free cash flow margin | (11.22%) | 2.17% | 0.00% |
| Return on equity | (64.91%) | 100.28% | (57.72%) |
| Return on assets | (18.32%) | 37.70% | (49.22%) |
| Return on invested capital | 0.00% | 10.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack